- Home
- ICUI
ICUI
ICU Medical Inc.
as 02-04-2025 4:00pm EST
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
| Founded: | 1984 | Country: | United States |
| Employees: | N/A | City: | SAN CLEMENTE |
| Market Cap: | 3.8B | IPO Year: | 1992 |
| Target Price: | $199.67 | AVG Volume (30 days): | 206.7K |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.57 | EPS Growth: | N/A |
| 52 Week Low/High: | $87.65 - $196.26 | Next Earning Date: | 02-25-2025 |
| Revenue: | $2,340,097,000 | Revenue Growth: | 4.04% |
| Revenue Growth (this year): | 4.38% | Revenue Growth (next year): | 0.34% |
Stock Insider Trading Activity of ICU Medical Inc. (ICUI)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Jain Vivek | ICUI | Chairman and CEO | Jan 2 '25 | Sell | $155.48 | 1,373 | $213,474.04 | 104,593 | |
| Woolson Daniel | ICUI | VP, GM-Infusion Capital | Dec 6 '24 | Sell | $156.25 | 2,241 | $350,158.49 | 10,866 | |
| Jain Vivek | ICUI | Chairman and CEO | Dec 2 '24 | Sell | $163.14 | 12,000 | $1,954,934.51 | 104,593 | |
| Voigtlander Christian B. | ICUI | Chief Operating Officer | Nov 27 '24 | Sell | $158.00 | 1,430 | $225,936.28 | 0 | |
| Greenberg David C. | ICUI | Director | Nov 27 '24 | Sell | $158.11 | 972 | $153,683.21 | 5,037 | |
| Voigtlander Christian B. | ICUI | Chief Operating Officer | Nov 25 '24 | Sell | $162.75 | 9,681 | $1,559,917.00 | 0 |
Latest ICU Medical Inc. News
ICUI Breaking Stock News: Dive into ICUI Ticker-Specific Updates for Smart Investing
Zacks
5 days ago
ResMed Inc. (RMD) Hits Fresh High: Is There Still Room to Run?
Argus Research
7 days ago
ICUI: Raising target price to $136.00
Argus Research
14 days ago
ICUI: Raising target price to $133.00
Argus Research
21 days ago
ICUI: Rating decreased to a SELL
GlobeNewswire
a month ago
ICU Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Simply Wall St.
a month ago
Calculating The Fair Value Of ICU Medical, Inc. (NASDAQ:ICUI)
Argus Research
a month ago
ICUI: Lowering target price to $162.00
Argus Research
2 months ago
ICUI: Lowering target price to $165.00
Compare ICUI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ICUI ICU Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.